Evolving role of radiation therapy for hematologic malignancies.
Radiation therapy continues to play a paramount role in the therapy of hematologic malignancies, whether as definitive therapy, as consolidation after chemotherapy, as part of bone marrow transplantation protocols, or in palliation. During the past 2 decades, significant advances in radiation therapy have occurred, including the evolution of involved-field irradiation and the adoption of conformal radiation administration. It is hoped that modern techniques will reduce the long-term sequelae associated with radiation-based treatments.
Lee
Chung K
CK
Department of Therapeutic Radiology-Radiation Oncology, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN 55455, USA. leexx006@umn.edu
D019337:Hematologic Neoplasms / Q000532:radiotherapy*; D006689:Hodgkin Disease / Q000473:pathology / Q000532:radiotherapy; D006801:Humans; D007938:Leukemia / Q000532:radiotherapy; D008228:Lymphoma, Non-Hodgkin / Q000532:radiotherapy; D009367:Neoplasm Staging; D010954:Plasmacytoma / Q000532:radiotherapy